Overview
- 12 inspections across 12 sites are on record.
- 3 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2019-09-20.
At a glance
Inspections
12
Sites
12
Observations
3
Career since
Jun 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Sitec Labs Limited | 20 Sep 2019 | Human Drugs | On file |
| Watson Pharma Private Ltd. | 13 Sep 2019 | Human Drugs | |
| XYLOPIA LABS PRIVATE LIMITED | 7 Sep 2018 | Human Drugs | |
| AXIS Clinicals Limited | 30 Aug 2018 | Human Drugs | |
| Reliance Life Sciences Private Limited | 11 Dec 2017 | Human Drugs |
Sites inspected
Sitec Labs LimitedNavi Mumbai, India1 insp.
Watson Pharma Private Ltd.Navi Mumbai, India1 insp.
XYLOPIA LABS PRIVATE LIMITEDAhmedabad, India1 insp.
AXIS Clinicals LimitedHyderabad, India1 insp.
Reliance Life Sciences Private LimitedNavi Mumbai, India1 insp.
Co-investigators
Investigators who share inspections with this person.
Hasan A Irier5 shared
Ruben C Ayala4 shared
Arindam Dasgupta2 shared
Nicola M Fenty-Stewart2 shared
V Ashutosh Rao1 shared
Mark W Babbitt1 shared
Full investigator report
Get the verbatim findings behind Young M Choi's 3 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site